UnitedHealth Group Optuminsight — D&A increased by 2.3% to $359.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.1%, from $332.00M to $359.00M. Over 3 years (FY 2021 to FY 2024), Optuminsight — D&A shows an upward trend with a 23.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase typically reflects higher capital expenditure on technology or significant recent acquisitions, while a decrease may indicate lower investment levels or the full amortization of older assets.
This metric represents the non-cash expense recognized by the Optum Insight segment to allocate the cost of tangible ass...
Comparable to depreciation and amortization expenses reported by other healthcare technology and data analytics firms, though it is heavily influenced by the specific M&A history of the reporting entity.
unh_segment_optum_insight_depreciation_and_amortization| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $171.00M | $171.00M | $171.00M | $210.25M | $210.25M | $210.25M | $210.25M | $307.25M | $307.25M | $307.25M | $307.25M | $310.00M | $316.00M | $332.00M | $336.00M | $344.00M | $351.00M | $359.00M |
| QoQ Change | — | +0.0% | +0.0% | +23.0% | +0.0% | +0.0% | +0.0% | +46.1% | +0.0% | +0.0% | +0.0% | +0.9% | +1.9% | +5.1% | +1.2% | +2.4% | +2.0% | +2.3% |
| YoY Change | — | — | — | — | +23.0% | +23.0% | +23.0% | +46.1% | +46.1% | +46.1% | +46.1% | +0.9% | +2.8% | +8.1% | +9.4% | +11.0% | +11.1% | +8.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.